Effects of human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues on CD34+ stem cells
Open Access
- 14 March 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 92 (4) , 484-488
- https://doi.org/10.1002/ijc.1222
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Chemokines and CD40 expression in human fibroblastsEuropean Journal of Immunology, 2000
- Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15Blood, 1998
- Adhesion Receptors as Regulators of the Hematopoietic ProcessBlood, 1998
- Phenotypic diversity in human fibroblasts from myelometaplasic and non‐myelometaplasic hematopoietic tissuesInternational Journal of Cancer, 1998
- Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.Journal of Clinical Investigation, 1998
- The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitorsBlood, 1995
- Quantitative variation of proto‐oncogene and cytokine gene expression in isolated breast fibroblastsInternational Journal of Cancer, 1995
- Myofibroblast and concurrent ED-B fibronectin phenotype in human stromal cells cultured from non-malignant and malignant breast tissueEuropean Journal Of Cancer, 1994
- Evidence of Fibroblast Heterogeneity and the Role of Fibroblast Subpopulations in FibrosisClinical Immunology and Immunopathology, 1994
- Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiationBlood, 1993